top of page
fotka.JPG

Prilagojeno po Angiopoietin_Infographic.pdf, https://www.scienceofang2.org/, Copyright 2020. The Angiogenesis Foundation, dostopano januar 2023.

SYMPOSIUM MONS'22

Stable coronary disease, Knowledge for daily practice XI.
NON-INVASIVE TREATMENT OF STABLE CORONARY DISEASE

14 January 2022 after 1.30 pm, Ljubljana

SiNAPSA Neuroscience Conference '21 (SNC'21) is the 9th biennial international neuroscience meeting organized by   SiNAPSA , Slovenian Neuroscience Association in partnership with the   Faculty of Medicine   of the University of Ljubljana.

 

SNC'21 program consists of plenary and special lectures, thematic symposia and short oral (poster) presentations covering all areas of neuroscience.

 

SNC'21 has an array of accompanying events: Dr. Janez Faganel Memorial Lecture and Ljubljana Clinical Neurophysiology Symposium (LCNS'21), Educational Workshop on CNS Protein Misfolding, Prof. Andrej O. Župančič Memorial Lecture and Neuroscience and Society Dialogue event, open for general public.

 

SNC'21 will be an entirely virtual event . There will be no participation fee, but the attendees have to register ahead of SNC'21, and the number of attendee slots will be limited.

Roche_Logo_800px_Blue_RGB (1).png
Program

THE PROGRAM

Wednesday, January 12, 2022

MONS after MONS 2021| 17:00

NOAK, Antiaggregation, Treatment of arterial hypertension

Thursday, January 13, 2022

MONS before MONS 2022 | 17:00– 19:30

POLYPRAGMASY

Moderator:Miha Šušteršič and Luka Lipar

Friday, January 14, 2022

Exhibition of openings| 13:40-15:30

New AHA-ACC guidelines for chest pain/Matjaž Bunc

Mechanisms of action of SGLT2, Inclisirana, PCSK-9, ARNI, vercigvata /Andraž Cerar

"Mons after Mons" Higlights: SGLT-2, Inclisar

High sensitivity ECG  /Miha Šusteršič

Coronary sinus flow restrictor - CFR /Miha Mrak

Infections and the heart /Janez Tomažič

15:30-15:45  INTRODUCTION | Patient with stable coronary disease: Treatment trends /Matjaž Bunc

Symposium I | 15:45-17:15 

THE LATEST APPROACHES TO LIMITING THE RISKS OF ATHEROSCLEROSIS 

Moderator:Mišo Šabovič and Zlatko Fras

ESC 2021 Highlights: Limiting the risk of AS

Effects of statins, ezetimibe, PCSK9 inhibitors, included / Zlatko Fras

Overview of antidiabetic therapy, new drugs and clinical indications /Aleš Skvarča

Antithrombotic therapy / Gregor Tratar

Renal denervation (RDN), arterial hypertension  / Dragan Kovačić

Optimal clinical practice - patient case /Miran Šebeštjen and Borut Jug

Questions and discussionMišo Šabovič in Zlatko Fras

17:15-17:20  A break

Symposium II | 17:20-18:20 

COMMON DILEMMA IN POLYMORBID PATIENTS 

Moderators:  Boris Krajačič, Simon Terseglav

Polypragmasy / Matej Marinšek

Measures in case of deterioration of kidney function / Jernej Pajek

Interactions between cardiac drugs, pollution and CVD diseases /Miran Brvar

Young people for young people: Polypragmatism Miha Šusteršič

Questions and discussionBoris Krajačič, Simon Terseglav

18:20-18:35 A break

Symposium III| 18:35-19:50

UNSPECIFIED CHEST PAIN 

Moderator:Matjaž Bunc and Miha Čerček

INOCA diagnostics (non-invasive INOCA diagnostics) /Borut Drnovšek

Nucleotide tests /Luka Ležaic

The role of CTA of the coronary arteries and MR of the heart /Tomaž Podlesnikar

Pulmonary hypertension / Polona Mlakar

Covid and the cardiovascular system  / Gradecki outlet

Acute consequences of Covid-19 on the heart: UKC Lj / Andreja Černa Čerček

Questions and discussion /Matjaž Bunc and Miha Čerček

19:50-19:55 A break

Round table | 19:55-20:40

TREATMENT OF THE FUTURE

Moderator:  Igor E. Bergant

 

Genetic diagnostics, genetic treatment /Borut Štrukelj, Borut Peterlin, Robert Zorec 

Closing of the meeting and summary

18:00–18:05 

18:05–18:15

18:15–18:30

18:30–18:45

18:45–19:00

Pozdravni nagovor

Fiziološka pot Ang-2 in njen učinek /

Ana Uršula Gavrič, dr.med., spec. oftalmologije

Patološka pot Ang-2 in njen učinek /

doc.dr. Mojca Urbančič, dr. med., spec. oftalmologije

Vloga Ang-2 pri mrežničnih in zunajočesnih patoloških stanjih /

prof.dr. Polona Jaki Mekjavić, dr. med., spec. oftalmologije

Diskusija ob vprašanjih

Prijava
PRIJAVA
arrow&v
Dogodek bom spremljal-a

 Zahvaljujemo se vam za prijavo! 

 

Na vaš e-naslov smo poslali potrdilo o prijavi in več podrobnosti glede udeležbe na simpoziju.

*S klikom na Shranjevanje osebnih podatkov se strinjate, da lahko hranimo vaše osebne podatke (kot so: ime, priimek, naslov, podatke o ustanovi, vaši specializaciji in vaš e-mail naslov) za namene prijave vaše udeležbe na strokovnem srečanju Ang-2 - nova doba zdravljenja mrežnice, 16.02.2023  in obveščanja o novicah v zvezi z omenjenim srečanjem.

Organizer:

SiNAPSA - Slovenian Neuroscience Association

The

Technical support:

Plant E-coopedu

The

Contact :

SNC21@sinapsa.org

Roche_Logo_800px_Blue_RGB (1).png

M-SI-00000751; Datum priprave informacije:  januar 2023. 
Samo za strokovno javnost.

DODATNE INFORMACIJE SO NA VOLJO PRI:

Roche farmacevtska družba d.o.o., Stegne 13g, Ljubljana

Technical and organizational support:

Institute for Professional Education and Innovation Support E-coopedu 

Contact:

info@ecoopedu.com

Web page:

www.ecoopedu.com

E-coopedu_logo.png
bottom of page